Jci_page_head_homepage_01 Jci_page_head_homepage_02
Michael J. Lodes, Yingzi Cong, Charles O. Elson, Raodoh Mohamath, Carol J. Landers, Stephan R. Targan, Madeline Fort, Robert M. Hershberg
Published in Volume 113, Issue 9
J Clin Invest. 2004; 113(9):1296–1306 doi:10.1172/JCI20295
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 9

Adoptive transfer of C3H/HeJBir CD4+ CBir1-specific T cell line into C3H/HeJ scid/scid recipients. (A) Two months after transfer, cecal and colon histopathology was assigned scores with a quantitative system (14). CD4+ T cells activated polyclonally with mAb against CD3 prior to transfer were used as a negative control (Anti-CD3_activated). A CBA-specific CD4+ T cell line reactive with unselected cecal bacterial antigens was used as a positive control (CBA-specific T cell line); the CBir1-specific CD4+ T cell line corresponds to the flagellin-specific T cell line in Figure 8. Sample size (n) is indicated at the top. (B) Representative histopathology of the groups shown in A: Anti-CD3_activated CD4+ T cells (top panel), CBir1 flagellin_specific CD4+ T cells (middle panel), and CBA-specific CD4+ T cells (bottom panel). Magnification, ∞200.